NOVAST LABS FDA Approval ANDA 202996

ANDA 202996

NOVAST LABS

FDA Drug Application

Application #202996

Application Sponsors

ANDA 202996NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-210.03MG;1.5MG0LARIN 1.5/30ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2014-03-20

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202996
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LARIN 1.5\/30","activeIngredients":"ETHINYL ESTRADIOL; NORETHINDRONE ACETATE","strength":"0.03MG;1.5MG","dosageForm":"TABLET;ORAL-21","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/20\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-03-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.